On the final day of subscriptions on Tuesday, December 24, investors from a wide range of categories continued to show a strong interest in Senores Pharmaceuticals' IPO.
When the Rs 582.11-crore Senores Pharmaceuticals initial public offering (IPO) opened for subscription on December 20, retail investors drove the oversubscription by more than 68 times.
Subscription across all categories
NSE data shows that the mainboard issue received bids for more than 58.23 crore shares, out of the 85.34 lakh shares available. This resulted in an overall subscription of 68.23 times until 5 pm on the final day of bidding.
A 79.50-fold overbooking occurred in the portion allocated to retail investors. Over 12.2 crore crore shares were put up for bid, out of the 15.46 lakh shares that were set aside for the category.
The segment of non-institutional investors (NIIs) was booked more than 87 times, with bids totaling more than 20.1 crore for the 23.2 lakh shares that were up for grabs.
The Qualified Institutional Buyers (QIBs) category received 55.83 bookings, with over 25.6 crore shares applied for out of the 45.93 lakh shares set aside for the segment. In contrast to allocating 75,000 shares, the company's employees booked their quota 18 times.
Senores Pharmaceuticals Limited IPO
— Thoughts Provoking (@thoughtsprovo) December 24, 2024
IPO Dates: December 20-24, 2024 Price Band: ₹372 - ₹391 Market Cap: ₹1,801 Cr
Highlights of the Issue:
Fresh Issue: ₹500 Cr
OFS: ₹82 Cr
Total Size: ₹582 Cr
Objects of the Issue:
Setting up Injectables Facility at… pic.twitter.com/eq9qTJMZsM
Issue size and price band
The company hopes to raise up to Rs 581.11 crore by selling its initial shares.
75 per cent of the offer size will go to the Qualified Institutional Buyers (QIBs), the company said. 10 per cent of the company's shares will go to retail investors, and 15 per cent will go to non-institutional investors.
Price band and minimum bid
An IPO price range of Rs 372 to Rs 391 per share has been established. Retail investors must bid at least 38 shares and their multiples. Retail investors must purchase a minimum of 38 shares, or Rs 14,858.
In terms of finances, Senores Pharma's operating revenue grew by a factor of 20 from Rs 35.34 crore to Rs 214.52 crore in fiscal 2024, and its profit after tax increased from Rs 8.43 crore to Rs 32.71 crore.
Company financials
In terms of finances, Senores Pharma's operating revenue grew by a factor of 20 from Rs 35.34 crore to Rs 214.52 crore in fiscal 2024, and its profit after tax increased from Rs 8.43 crore to Rs 32.71 crore.